Peregrine Pharmaceuticals, Inc.
(NASDAQ : PPHM)

( )
PPHM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading PPHM News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
0.51%971.737.5%$341.77m
MDTMedtronic PLC
0.02%85.670.6%$315.38m
ABTAbbott Laboratories
2.91%50.870.8%$291.87m
BDXBecton, Dickinson and Company
0.74%203.521.3%$235.13m
TMOThermo Fisher Scientific Inc.
0.82%181.631.0%$214.70m
ZBHZimmer Biomet Holdings, Inc.
-1.21%129.491.7%$198.26m
BSXBoston Scientific Corporation
-0.64%27.751.1%$175.19m
BCRC. R. Bard, Inc.
0.27%321.811.6%$149.76m
SYKStryker Corporation
0.81%147.411.3%$149.55m
BAXBaxter International Inc.
0.99%63.071.7%$145.25m
EWEdwards Lifesciences Corporation
0.39%119.501.2%$121.66m
SPNCSpectranetics Corporation
0.00%38.458.4%$120.73m
ALGNAlign Technology, Inc.
0.56%160.176.2%$118.45m
COOCooper Companies, Inc.
-0.38%253.942.2%$114.60m
HOLXHologic, Inc.
0.29%45.411.6%$104.76m

Company Profile

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the provision of monoclonal antibody therapeutics. It operates through Peregrine and Avid segments. The Peregrine segment refers to research and development of monoclonal antibodies for the treatment and diagnosis of cancer. The Avid segment provides contract management services for peregrine and third-party customers on a fee-for-services basis. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.